Data / Form D filings / Halia Therapeutics, Inc.
Halia Therapeutics, Inc.: Form D filings
Halia Therapeutics, Inc., a biotechnology company in Lehi, UT, filed 5 Form D notices with the SEC between 2020 and 2026. The latest, on August 31, 2026, reports $3.5 million sold of a $20 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3900 N. Traverse Mountain Blvd. Suite 100, Lehi, UT, 84043
- Phone
- (801) 842-1652
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1829255
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | New notice | $20,000,000 | $3,486,474 | $16,513,526 | 9 | Aug 17, 2026 | sec.gov |
| Jul 16, 2025 | New notice | $19,999,996 | $336,833 | $19,663,163 | 5 | Jul 1, 2025 | sec.gov |
| Dec 30, 2022 | New notice | $49,999,991 | $12,223,338 | $37,776,653 | 24 | Dec 16, 2022 | sec.gov |
| Feb 17, 2021 | New notice | $5,000,000 | $4,999,994 | $6 | 5 | Feb 3, 2021 | sec.gov |
| Oct 22, 2020 | New notice | $15,000,000 | $6,344,990 | $8,655,010 | 9 | Oct 9, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jeffrey Burton | Executive Officer | |
| David Bearss | Director | |
| David Checketts | Director | |
| John S.K. Kauwe | Director | |
| Gary B. Sabin | Director | |
| Mary Beckerle | Director | |
| Preston Campbell | Director |
Other biotechnology companies in Utah that filed recently
- Life Impact Partners 1 LLC offering · Oct 22, 2026
- 3Helix, Inc. $7.8 million · Sep 21, 2026
- Paterna BioSciences HoldCo Inc. $6.3 million · Aug 12, 2026
Every Form D from the week of Aug 31, 2026 · All recent filings in Utah · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Halia Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.